FindTrial
Sign In

Assessment Of changes in serum Prestin levels as an inner ear biomarker in patients with severe to profound hearing loss undergoing cochlear implant surgery

ASSESSMENT OF CHANGES IN SERUM PRESTIN LEVELS AS AN INNER EAR BIOMARKER IN PATIENTS WITH SEVERE TO PROFOUND HEARING LOSS UNDERGOING COCHLEAR IMPLANT SURGERY - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082688
Enrollment
30
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q165- Congenital malformation of inner ear

Interventions

None listed

Sponsors

AIIMS Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children from 6 months to 5 years of age with sever to profound hearing loss undergoing cochlear implant surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
to see changes in serum Prestin levels before and after treatment with comparison to normal populationTimepoint: 12 -24 hours before surgery, 24 hours after surgery—

Secondary

MeasureTime frame
to draw a comparison between serum values of the patients & a control group with no hearing lossTimepoint: 24 hours before surgery, 12-24 hours after surgery—

Countries

India

Contacts

Public ContactDr Amit Goyal

AIIMS Jodhpur

meetugoyal@yahoo.com09649954000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026